Download PDF
Klin Padiatr 2001; 213(1): 1-7
DOI: 10.1055/s-2001-11264
ÜBERSICHT

Georg Thieme Verlag Stuttgart · New York

Myokarditis im Kindesalter - Forschungsergebnisse einer Dekade

Myocarditis in infancy and childhood. A decade researchA.  A.  Schmaltz1 , R.  Kandolf2
  • 1Abteilung für Pädiatrische Kardiologie, Zentrum für Kinder- und Jugendmedizin, Universität Essen
  • 2Abteilung für Molekulare Pathologie, Institut für Pathologie, Universitätsklinikum Tübingen
Further Information

Publication History

Publication Date:
31 December 2001 (online)

Also available at
    Permissions and Reprints

Zusammenfassung.

Die Forschungsergebnisse des letzten Jahrzehnts haben uns im pathogenetischen Verständnis der Myokarditis erheblich vorangebracht. Die Virusinfektion des Myokards kann durch das entzündliche Infiltrat kontrolliert werden, die Myokarditis mit geringer oder deutlicher Narbenbildung ausheilen. Daneben wird eine autoimmunvermittelte chronische Myokarditis beobachtet sowie eine Persistenz des Virusgenoms, das mit geringer Replikationsrate den Entzündungsprozess unterhält. Die immunhistochemische Charakterisierung des Infiltrates sowie der molekularbiologische Nachweis von Virusgenom in der Endomyokardbiopsie ermöglichen eine empfindliche Diagnostik der verschiedenen Formen der Myokarditis, nach denen sich auch die Therapie ausrichten sollte. Bisherige Therapiestudien kranken an der mangelhaften ätiologischen Diagnostik, fehlenden Kontrollgruppen oder kleinen Zahlen. Zwei multizentrische Therapiestudien zur immunsuppressiven und antiviralen Therapie mit Interferon bei Kindern und bei Erwachsenen können bei besserer Beteiligung Therapieempfehlungen geben.

The research of the last decade gave new insights in the pathogenesis of viral myocarditis. The virus infection of the myocardium may be controlled by the infiltrating inflammatory cells and heal with more or less scarring. An autoimmune mediated chronic inflammation is observed as well as the persistence of virus genoms, which causes with low replication rate again chronic inflammation. The immunohistochemical characterization of the infiltrating immune cells and the molecular biological proof of virus genoms in endomyocardial specimens allow a sensitive diagnostic of the various forms of myocarditis and should guide therapy. Until now treatment trials did not differentiate between these various forms, had no control groups or very small numbers of patients. Two multicenter treatment trials in Germany referring to immunosuppressive or interferon therapy in children and adults may give - provided a better participation - recommendations for therapy.

Schlüsselwörter

Myokarditis - Kindesalter - Pathogenese - Therapie

Key words

myocarditis - infancy and childhood - pathogenesis - treatment

Literatur

  • 01 Akhtar  N, Ni  J, Stromberg  D, Rosenthal  G L, Bowles  N E, Towbin  J A. Tracheal aspirate as a substrate for polymerase chain reaction detection of viral genome in childhood pneumonia and myocarditis.  Circulation. 1999;  99 2011-2018
    Google Scholar
  • 02 Arbustini  E, Gavazzi  A, Dal Bello  B, Morbini  P, Campana  C, Diegoli  M, Grasso  M, Fasani  R, Banchieri  N, Porcu  E, Pilotto  A, Ponzetta  M, Bellini  O, Lucreziotti  S, Vigano  M. Ten-years experience with endomyocardial biopsy in myocarditis presenting with congestive heart failure: frequency, pathologic characteristics, treatment and follow-up.  G Ital Cardiol. 1997;  27 209-223
    Google Scholar
  • 03 Aretz  H AT, Billingham  M E, Edwards  W D, Factor  S M, Fallon  J T, Fenoglio  J J, Olsen  E GJ, Schoen  F J. Immunosuppressive therapy of chronic myocarditis in children: Three cases and the design of a randomized prospective trial of therapy.  Pediatr Cardiol. 1998;  19 235-239
    Google Scholar
  • 04 Balaji  S, Wiles  H B, Sens  M A, Gillette  P C. Immunosuppressive treatment for myocarditis and borderline myocarditis in children with ventricular ectopic rhythm.  Br Heart J. 1994;  72 354-359.
    Google Scholar
  • 05 Bastanier  C K, Schmaltz  A A, Kandolf  R, Hofstetter  R. Parvo B-19 Infektion des Herzens. Ein ätiologischer Faktor zur Entstehung Dilatativer Kardiomyopathien im Kindesalter?.  Z Kardiol. 1999;  88 728
    Google Scholar
  • 06 Billingham  M E. Myocarditis and endomyocardial biopsy (letter).  Ann Intern Md. 1989;  110 165-166
    Google Scholar
  • 07 Boreda  D, Palomera  S, Gilbert  B, Lienhardt  A, deLumley  L. 24 cases of human parvovirus B 19 infection in children.  Ann Pediatr. 1992;  39 543-549
    Google Scholar
  • 08 Bültmann  B, Kandolf  R. Persönliche Mitteilung.  1997
    Google Scholar
  • 09 Caforio  A LP, Goldmann  J H, Haven  A J, Saig  K M, Dalla Libera  L, McKenna  W J. Circulating cardiac-specific autoantibodies as markers of autoimmunity in clinical and biopsy-proven myocarditis.  Europ Heart J. 1997;  18 270-275
    Google Scholar
  • 10 Camargo  P R, Snitcowsky  P, da Luz  P L, Mazzieri  P, Higuchi  M L, Rati  M, Stolf  N, Ebai  M, Pileggi  F. Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis.  Pediatr Cardiol. 1995;  16 61-68
    CrossrefPubMedGoogle Scholar
  • 11 Chen  J M, Spanier  T B, Gonzalez  J J, Marelli  D, Flannery  F MA, Tector  K A, Cullinane  S, Oz  M C. Improved survival in patients with acute myocarditis using external pulsatile mechanical ventricular assistance.  J Heart Lung Transplant. 1999;  18 351-357
    PubMedGoogle Scholar
  • 12 Chen  Y S, Wang  M J, Chou  N K, Han  Y Y, Chiu  I S, Lin  F Y, Chu  S H, Ko  W J. Rescue for acute myocarditis with shock by extracorporeal membrane oxygenation.  Ann Thorac Surg. 1999;  69 2220-2224
    PubMedGoogle Scholar
  • 13 deSa  D J. Isolated myocarditis as a cause of sudden death in the first year of life.  Forensic Sci Int. 1986;  30 113-117
    CrossrefPubMedGoogle Scholar
  • 14 Drucker  N A, Colan  S D, Leweis  A B, Beiser  A S, Wessel  D L, Takahashi  M, Baker  A L, Perez-Atayde  A R, Newburger  J W. γ-globulin treatment of acute myocarditis in the pediatric population.  Circulation. 1994;  89 252-257
    PubMedGoogle Scholar
  • 15 Heim  A, Stille-Siegener  M, Kandolf  R, Kreuzer  H, Figulla  H R. Enterovirus-induced myocarditis: Hemodynamic deterioration with immunosuppressive therapy and successful application of interferon-α.  Clin Cardiol. 1994;  17 563-565
    PubMedGoogle Scholar
  • 16 Heim  A, Brehm  G, Stille-Siegener  M, Müller  G, Hake  S, Kandolf  R, Figulla  H R. Cultured human myocardial fibroblasts of pediatric origin: natural human interferon-α is more effective than recombinant interferon-α 2a in carrier-state Coxsackievirus B3 replication.  J Mol Cell Cardiol. 1995;  27 2199-2208
    CrossrefPubMedGoogle Scholar
  • 17 Heusch  A, Kühl  U, Rammos  S, Krogmann  O N, Schultheiss  H-P, Bourgeois  M. Complete AV-block in two children with immunohistological proven myocarditis.  Eur J Pediatr. 1996;  155 633-636
    CrossrefPubMedGoogle Scholar
  • 18 Johnsrude  C L, Pery  J C, Cecchin  F, Smith  E O, Fraley  K, Friedman  R A, Towbin  J A. Differentiating anomalous left main coronary artery originating from the pulmonary artery in infants from myocarditis and dilated cardiomyopathy by electrocardiogram.  Am J Cardiol. 1995;  75 71-74
    CrossrefPubMedGoogle Scholar
  • 19 Kadirova  R, Kartoglu  H U, Strebel  M P. Clinical characteristics and management of 676 hospitalized diphtheria cases, Kyrgyz Republic, 1995.  J lnfect Dis. 2000;  181 110-115
    PubMedGoogle Scholar
  • 20 Kallenberg  R, Andelfinger  B, Barth  H, Frasch  W, Harding  P, Hussein  A, Hofbeck  M, Klabus  D, Köhler  W, Koch  A, Lang  D, Levin  M, Liersch  R, Müller-Scholden  J, Paul  T, Rüdiger  H, Sort  J, Schulz  R, v. Walter  J, Wimmer  M, Wippermann  C F, Schmaltz  A A. Myokarditis/DCM im Kindesalter - Bericht über die Registermeidungen für 1994.  Z Kardiol. 1995;  84 782
    PubMedGoogle Scholar
  • 21 Kandolf  R, Ameis  D, Kirschner  P, Canu  A, Hofschneider  P H. In situ detection of enteroviral genomes in myocardial cells by nuclei acid hybridization: an approach to the diagnosis of viral heart disease.  Proc Natl Acad Sci USA. 1987;  84 6272-6276
    PubMedGoogle Scholar
  • 22 Kandolf  R, Klingel  K, Zell  R, Sekinka  H C, Raab  U, Schneider-Brachert  W, Bültmann  B. Molecular pathogenesis of enterovirus-induced myocarditis: virus persistence and chronic inflammation.  Intervirology. 1993;  35 140-151
    PubMedGoogle Scholar
  • 23 Kandolf  R, Sauter  M, Aepinus  C, Schnorr  J J, Selinka  H-C, Klingel  K. Mechanisms and consequences of enterovirus persistence in cardiac myocytes and cells of the immune system.  Virus Research. 1999;  62 149-158
    CrossrefPubMedGoogle Scholar
  • 24 Kececioglu  D, Gehrmann  J, Mugler  M, Rossi  R, Vogt  J. Myokarditis simuliert akuten Myokardinfarkt im Säuglingsalter.  Herz/Kreisl. 1993;  25 353-355
    PubMedGoogle Scholar
  • 25 Killian  J G, Kerr  K, Lawrence  C, Gelermajer  D S. Myocarditis and cardiomyopathy associated with clozapine.  Lancet. 1999;  354 1841-1845
    CrossrefPubMedGoogle Scholar
  • 26 Kleinert  S, Weintraub  R G, Wilkinson  J L, Chow  C W. Myocarditis in children with dilated cardiomyopathy: incidence and outcome after dual therapy immunosuppression.  J Heart Lung Transplant. 1997;  16 1248-1254
    PubMedGoogle Scholar
  • 27 Klingel  K, Hohenadl  C, Canu  A, Albrecht  M, Seemann  M, Mall  G, Kandolf  R. Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation.  Proc Natl Acad Sci USA. 1992;  89 314-318
    PubMedGoogle Scholar
  • 28 Klingel  K, Rieger  P, Mall  G, Selinka  H C, Huber  M, Kandolf  R. Visualization of enteroviral replication in myocardial tissue by ultrastrctural in situ hybridization: identification of target cells and cytopathic effects.  Lab lnvest. 1998;  78 1227-1237
    PubMedGoogle Scholar
  • 29 Kodama  M, Hanawa  H, Zhang  S, Saeki  M, Koyama  S, Hosono  H, Miyakita  Y, Kathoh  K, Inomata  T, Izumi  T, Shibata  A. FK 506 therapy of experimental autoimmune myocarditis after onset of the disease.  Am Heart J. 1993;  126 1385-1392
    CrossrefPubMedGoogle Scholar
  • 30 Kodama  M, Zhang  S, Hanawa  H, Saeki  M, Inomata  T, Suzuki  K, Koyama  S, Shibata  A. Effects of 15-deoxyspergualin on experimental autoimmune giant cell myocarditis of the rat.  Circulation. 1995;  91 1116-1122
    PubMedGoogle Scholar
  • 31 Kyu  B S, Matsamori  A, Sato  Y, Okada  J, Chapman  N M, Tracy  S. Cardiac persistence of cardioviral RNA detected by polymerase chain reaction in a murine model of dilated cardiomyopathy.  Circulation. 1992;  86 522-530
    PubMedGoogle Scholar
  • 32 Lauer  B, Padberg  K, Schultheiss  H-P, Strauer  B-E. Autoantibodies against human ventricular myosin in sera of patients with acute and chronic myocarditis.  J Am Coll Cardiol. 1994;  23 146-153
    PubMedGoogle Scholar
  • 33 Lauer  B, Niederau  C, Kühl  U, Schannwell  M, Pauschinger  M, Strauer  B E, Schultheiss  H P. Cardiac troponin T in patients with clinically suspected myocarditis.  J Am Coll Cardiol. 1997;  30 1354-1359
    CrossrefPubMedGoogle Scholar
  • 34 Lee  K J, McCrindle  B W, Bohn  D J, Wilson  G J, Taylor  G P, Freedom  R M, Smallhorn  J F, Benson  L N. Clinical outcomes of acute myocarditis in childhood.  Heart. 1999;  82 226-233
    PubMedGoogle Scholar
  • 35 Liu  P, Wang  E EL, Sole  M. Viral myocarditis: Changing concepts in pathogenesis and implications in diagnosis and treatment.  Cardiovasc Pathol. 1993;  2 247-257
    CrossrefPubMedGoogle Scholar
  • 36 Loukoushkina  E F, Bobko  P V, Kolbasova  E V, Kazakova  L V, Krasnov  V V, Shipova  L G, Lazarea  T S, Vlasova  I N, Schmaltz  A A. The clinical picture and diagnosis of diphtheritic carditis in children.  Eur J Pediatr. 1998;  157 528-533
    CrossrefPubMedGoogle Scholar
  • 37 Martin  A B, Webber  S, Fricker  F J, Jaffe  R, Demmler  G, Kearney  D, Zhang  Y-H, Bodurtha  J, Gelb  B, Ni  J, Bricker  J T, Towbin  J A. Acute myocarditis-rapid diagnosis by PCR in children.  Circulation. 1994;  90 330-339
    PubMedGoogle Scholar
  • 38 Mason  J W, O'Connell  J B, Herskowitz  A, Rose  N R, McManus  B M, Billingham  M F, Moon  T E. A clinical trial of immunosuppressive therapy for myocarditis.  N Engl J Med. 1995;  333 269-275
    CrossrefPubMedGoogle Scholar
  • 39 McCarthy  R E, Boehmer  J P, Hruban  R H, Hutchins  G M, Kasper  E K, Hare  J M, Baughman  K L. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis.  N Eng J Med. 2000;  432 690-695
    PubMedGoogle Scholar
  • 40 McNamara  D M, Rosenblum  W D, Janosko  K M, Trost  M K, Villaneuva  F S, Demetris  A J, Murali  S, Feldmann  A M. Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy.  Circulation. 1997;  95 2476-2478
    PubMedGoogle Scholar
  • 41 Maisch  B, Trostel-Soeder  R, Stechemesser  E, Berg  P A, Kochsiek  K. Diagnostic relevance of humoral and cell-mediated immune reactions im patients with acute viral myocarditis.  Clin Exp Immunol. 1982;  48 533-545
    PubMedGoogle Scholar
  • 42 Maisch  B, Hufnagel  G, Schönian  U, Hengstenberg  C. European study of epidemiology and treatment of cardiac inflammatory disease (ESETCID).  Eur Heart J. 1996;  16 173-175
    PubMedGoogle Scholar
  • 43 Miric  M, Miskovic  A, Brkic  S, Vasiljevic  J, Keserovic  N, Pesic  M. Long-term follow-up of patients with myocarditis and idiopathic dilated cardiomyopathy after immunomudulatory therapy.  FEMS Immun Med Microbiol. 1994;  10 65-74
    PubMedGoogle Scholar
  • 44 Nakagawa  M, Sato  A, Okagawa  H, Kondo  M, Okuno  M, Takamatsu  T. Detection and evaluation of asymptomatic myocarditis in schoolchildren: report of four cases.  Chest. 1999;  116 340-345
    CrossrefPubMedGoogle Scholar
  • 45 Nishio  R, Matsumori  A, Shioi  T, Ishida  H, Sasayama  S. Treatment of experimental viral myocarditis with interleukin-10.  Circulation. 1999;  100 1102-1108
    PubMedGoogle Scholar
  • 46 Pauschinger  M, Doerner  A, Kuehl  U, Schwimmbeck  P L, Poller  W, Kandolf  R, Schultheiss  H-P. Enteroviral RNA replication in the myocardium of patients with left ventricular dysfunction and clinically suspected myocarditis.  Circulation. 1999;  99 889-895
    PubMedGoogle Scholar
  • 47 Rajs  J, Hammarquist  F. Sudden infant death in stockholm. A forensic pathology study covering ten years.  Acta Paediatr Scand. 1988;  6 712-720
    PubMedGoogle Scholar
  • 48 Rautenburg  H W. Klinik und Therapie entzündlicher Herzerkrankungen.  In: H. Singer (Hrsg.) Herzerkrankungen im Kindes- und Jugendalter. Perimed Erlangen; 1989: 172-186
    Google Scholar
  • 49 Saint-Martin  J, Bonnaud  E, Morinet  F, Choulot  J J. A Mensire Acute parvovirus myocarditis with fatal outcome.  Pediatrie. 1991;  46 597-599
    PubMedGoogle Scholar
  • 50 Schmaltz  A A. Die Myokarditis im Kindesalter.  Klin Pädiatr. 1991;  203 1-7
    PubMedGoogle Scholar
  • 51 Schmaltz  A A, Demel  K P, Kallenberg  R, Neudorf  U, Kandolf  R, Klingel  K, Bültmann  B. Immunosuppressive therapy of chronic myocarditis in children: three cases and the design of a randomized prospective trial of therapy.  Pediatr Cardiol. 1998;  19 235-239
    CrossrefPubMedGoogle Scholar
  • 52 Schowengerdt  K O, Ni  J, Denfield  S W, Gajarski  R J, Bowles  N P, Rosenthal  G, Kearney  D L, Price  J K, Rogers  B B, Schauer  G M, Chinnock  R E, Towbin  J A. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction.  Circulation. 1997;  96 3549-3554
    PubMedGoogle Scholar
  • 53 Schowengerdt  K O, Ni  J, Denfield  S W, Gajarski  R J, Radovancevic  S, Frazier  H O, Demmler  G J, Kearney  D, Bricker  J T, Towbin  J A. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.  J Heart Lung Transplant. 1996;  15 111-123
    PubMedGoogle Scholar
  • 54 Schultheiß  H P. Die dilatative Kadiomyopathie - eine chronische Myokarditis? Neue Aspekte zur Diagnostik und Therapie.  Z Kardiol. 1993;  82 (Suppl 4) 25-33
    PubMedGoogle Scholar
  • 55 Shah  S S, Hellenbrand  W E, Gallagher  P G. Atrial flutter complicating neonatal coxsackie B2 myocarditis.  Pediatr Cardiol. 1998;  19 185-186
    CrossrefPubMedGoogle Scholar
  • 56 Shanes  J G, Ghali  J, Billingham  M E, Ferrans  V J, Fenoglio  J J, Edwards  W D, Tsai  C C, Saffitz  J E, Isner  J, Furner  S, Subramanian  R. Interobserver variability in the pathologic interpretation of endomyocardial biopsy results.  Circulation. 1987;  75 401-405
    CrossrefPubMedGoogle Scholar
  • 57 Stiller  B, Dähnert  I, Wenig  Y G, Henning  E, Hetzer  R, Lange  P E. Children may survive severe myocarditis with prolonged use of biventricular assist devices.  Heart. 1999;  82 237-240
    PubMedGoogle Scholar
  • 58 Stastny  B, Leonhardt-Horti  H, Hagel  K J, Schranz  D. Fulminant diphtheria myxocarditis in an unvaccinated preschool child.  Klin Pädiatr. 1999;  6 462-464
    PubMedGoogle Scholar
  • 59 Tomioka  N, Kishimoto  C, Matsurmori  A, Kawai  C H. Effects of prednisolone on acute viral myocarditis in mice.  J Am Coll Cardiol. 1987;  7 868-872
    PubMedGoogle Scholar
  • 60 Torres  F, Anguita  M, Gimenez  D, Mesa  D, Tejero  I, Ranco  M, Benitez  F, Amat  M, Valles  F. Long-term clinical course of acute myocarditis. prospective study of a series of 99 patients (1987 - 1995).  Rev Esp Cardiol. 1996;  49 723-731
    PubMedGoogle Scholar

Prof. Dr. med. A. A. Schmaltz

Abteilung Pädiatrische KardiologieUniversitätskinderklinik

Hufelandstr. 55

45122 Essen

Phone: Tel. 0201/723-2452

Fax: Fax 0201/723-5743

Email: E-mail: achim.schmaltz@uni-essen.de

      >